Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • NCD 2025
NET Nurse
Donate

Home » News » Oncology for the Inquisitive Mind

Oncology for the Inquisitive Mind

  • October 5, 2023

 

Dr Josh Hurwitz and Dr Michael Fernando have created a podcast service “Oncology for the Inquisitive Mind”.

NECA was fortunate to have the opportunity to be a guest on this podcast on Thursday 28 September 2023. During the interview NECA was able to provide an overview of our achievements to date including the National Awareness Campaign, an overview of NeuroEndocrine Cancer Australia and it’s services, a background on NETs, incidence & prevalence, misdiagnosis, patient challenges, and  clinician challenges.

The NET Education Modules were discussed for HCPs, the launch of the Optimal Care Pathway (OCP) and the benefits of the NET OCP and quick reference guide. NECA’s National Action Plan featured ad highlighted the need for funding for support and research. Josh and Michael updated the listeners on current clinical trials available in Australia.

NECA explained the PLANET Registry and the NET Centres of Excellence around Australia. The interview concluded with the challenges which continue to be experienced and what would be  on our wish list to rectify and improve outcomes for NET patients. Thank you so much Josh and Michael for enabling NECA to have a voice and convey the needs of the NETs community.

This podcast spans every continent (>100 countries) with the biggest audience being Australia, USA and the UK followed by Canada and Germany.

You can listen to the full podcast HERE.

 

Share this post

Recent posts

Neuroendocrine Cancer Day 2025

November 12, 2025

NECA attends ACNNP Governance Group Day

November 11, 2025

Ipsen’s Lunch and Learn with NECA for Neuroendocrine Cancer Day

November 11, 2025

Equitable Access to Cancer Care: Reflections from Parliament House

October 31, 2025
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousOnline survey for NET patients
NextMeeting with Dr Gordon Reid Federal Labor Member for RobertsonNext

Related Posts

Neuroendocrine Cancer Day 2025

On Monday November 10, our incredible NET community came together to mark Neuroendocrine Cancer Day, a day dedicated to raising awareness and recognising everyone affected

Ipsen’s Lunch and Learn with NECA for Neuroendocrine Cancer Day

In recognition of Neuroendocrine Cancer Day, NeuroEndocrine Cancer Australia (NECA) was invited to speak at Ipsen’s Lunch and Learn event. The session brought together Ipsen team

Racing for a Cure 2025

On Friday 24 October, the Flinders Island community once again rallied behind Rob Hammond and Racing for a Cure for its fourth consecutive year, delivering

NECA Highlights Gaps in Government’s Senate Inquiry Response

After 458 days of waiting, the Government finally released its response to the Senate  Inquiry into Rare and Less Common Cancers, including Neuroendocrine Cancer, on

View All

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2025 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin